In regions of declining malaria transmission, new strategies for control are needed to reduce transmission and achieve elimination. Artemisinin-combination therapy (ACT) is active against immature gametocytes and can reduce the risk of transmission. We sought to determine whether household screening and treatment of infected individuals provides protection against infection for household members.
The study was conducted in two areas in Southern Province, Zambia in 2007 and 2008/2009. To determine the impact of proactive case detection, households were randomly selected either to join a longitudinal cohort, in which participants were repeatedly screened throughout the year and those infected treated with artemether-lumefantrine, or a cross-sectional survey, in which participants were visited only once. Cross-sectional surveys were conducted throughout the year. The prevalence of RDT positivity was compared between the longitudinal and cross-sectional households at baseline and during follow-up using multilevel logistic regression. In the 2007 study area, 174 and 156 participants enrolled in the cross-sectional and longitudinal groups, respectively. In the 2008/2009 study area, 917 and 234 participants enrolled in the cross-sectional and longitudinal groups, respectively. In both study areas, participants and households in the longitudinal and cross-sectional groups were similar on demographic characteristics and prevalence of RDT positivity at baseline (2007: OR = 0.97; 95% CI:0.46, 2.03 | 2008/2009: OR = 1.28; 95% CI:0.44, 3.79). After baseline, the prevalence of RDT positivity was significantly lower in longitudinal compared to cross-sectional households in both study areas (2007: OR = 0.44; 95% CI:0.20, 0.96 | 2008/2009: OR = 0.16; 95% CI:0.05, 0.55).
Proactive case detection, consisting of screening household members with an RDT and treating those positive with ACT, can reduce transmission and provide indirect protection to household members. A targeted test and treat strategy could contribute to the elimination of malaria in regions of low transmission.
Citation: Sutcliffe CG, Kobayashi T, Hamapumbu H, Shields T, Mharakurwa S, Thuma PE, et al. (2012) Reduced Risk of Malaria Parasitemia Following Household Screening and Treatment: A Cross-Sectional and Longitudinal Cohort Study. PLoS ONE 7(2): e31396. https://doi.org/10.1371/journal.pone.0031396
Editor: Lorenz von Seidlein, Menzies School of Health Research, Australia
Received: June 30, 2011; Accepted: January 6, 2012; Published: February 3, 2012
Copyright: © 2012 Sutcliffe et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the Johns Hopkins Malaria Research Institute and the Bloomberg Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
An estimated 225 million cases of malaria and 781,000 deaths occurred worldwide in 2009, with the majority in the African region . In the past decade, international support and funding for malaria control increased dramatically and targets were set to increase coverage of interventions to over 80% by 2010, reduce the burden of malaria by 75% by 2015 , and eliminate malaria in 8–10 countries by 2015 . This renewed commitment to malaria elimination has been made possible with increased coverage of four key interventions: insecticide-treated nets (ITNs), indoor residual spraying (IRS) of targeted households, treatment with artemisinin-combination therapy (ACT), and intermittent preventive treatment for high-risk groups including pregnant women and infants. Programs that have achieved high coverage with these interventions have shown dramatic decreases in the number of malaria cases, admissions and deaths , , , , and 11 African countries have demonstrated large (>50%) and sustained decreases in the burden of malaria .
Several case detection strategies have been implemented in regions affected by malaria . Many programs rely on identification of symptomatic individuals at healthcare facilities (passive case detection). However, the prevalence of asymptomatic or minimally symptomatic parasitemia in a population can be as high as 35% , , , . As these individuals do not exhibit symptoms severe enough to seek care, their infections go untreated, thereby serving as parasite reservoirs that can maintain transmission. Consequently, additional strategies are needed, particularly in areas of declining transmission. An alternate strategy is to screen individuals for parasitemia and provide treatment to those who are infected (proactive case detection or focal screening and treatment) , thereby identifying and treating asymptomatic or minimally symptomatic individuals. Use of ACT can enhance this strategy as it is active against immature gametocytes . Treatment not only reduces the burden of parasites within the individual but can reduce the risk of transmission to mosquitoes , . In regions of declining transmission, the burden of malaria could potentially be reduced to such an extent that elimination is achievable.
Using a series of longitudinal and cross-sectional household surveys in a setting of declining malaria transmission in southern Zambia, we sought to quantify the effect of proactive case detection by screening individuals within households and treating those infected with ACT. We hypothesized that the prevalence of infection would be lower in households in the longitudinal cohort where individuals were repeatedly tested and treated compared to households in the cross-sectional surveys where individuals were tested and treated once.
The study was approved the University of Zambia Research Ethics Committee and the Institutional Review Board at the Johns Hopkins Bloomberg School of Public Health.
This study was conducted within the context of an epidemiologic study to determine changes in the prevalence of parasitemia and gametocytemia in a region of unstable malaria transmission in southern Zambia , . To determine the impact of proactive case detection, households were randomly selected either to join a longitudinal cohort, in which participants were repeatedly screened throughout the year and those infected treated with ACT, or a cross-sectional survey, in which participants were visited only once. A series of cross-sectional surveys was conducted throughout the year to account for any temporal and seasonal changes in transmission.
The study was conducted in the catchment area of Macha Hospital in Choma District, Southern Province, Zambia between April 2007 and December 2009. Macha Hospital is located approximately 70 km from the nearest town of Choma on a plateau at an altitude of approximately 1,100 meters above sea level and in a habitat characterized as Miombo woodland. There is a single rainy season from approximately November through April, followed by a cool, dry season from April to August, and a hot, dry season from August to November. The catchment area is populated by traditional villagers living in small, scattered homesteads. Anopheles arabiensis is the primary vector responsible for malaria transmission , which peaks during the rainy season.
The Southern Province of Zambia historically had hyperendemic transmission of Plasmodium falciparum . More recently, the entomological inoculation rate for An. arabiensis was estimated to range from 1.6 to 18.3 infective bites per person per season  and the number of children hospitalized for malaria decreased dramatically (unpublished data). Zambia introduced artemether-lumefantrine as antimalarial therapy in 2002, and insecticide-treated bed nets (ITNs) were widely distributed in Southern Province, Zambia in 2007 . Widespread IRS has not been formally conducted in the study area.
The study site in 2007 consisted of a 525 km2 region east of Macha Hospital (Figure 1). In 2008 and 2009, the study site was shifted to an adjacent 575 km2 area west of the 2007 study site and closer to Macha Hospital. This was done for logistical reasons as distances to the study households proved to be difficult to navigate operationally, particularly during the rainy season when roads and bridges were flooded.
At the beginning of the study in each site, satellite images were used to construct a sampling frame for the random selection of households to be enrolled in a prospective longitudinal cohort study and serial cross-sectional surveys. The sampling frame was constructed from a Quickbird™ satellite image obtained from DigitalGlobe Services, Inc. (Denver, Colorado). The image was imported into ArcGIS 9.2 (Redlands, CA) and locations of households were identified and enumerated manually. In this area, households consist of one or more domestic structures where members of a family or extended family reside. Operationally, structures of appropriate size and shape situated within cleared sections of land approximately 50 meters wide were identified as potential residences from the satellite image. Satellite images have been used successfully to establish a sampling frame in Zambia . The desired number of households was randomly selected from the sampling frame to be enrolled in the longitudinal cohort study. From the remaining households, the desired number of households was randomly selected without replacement to be enrolled in each of the cross-sectional surveys conducted throughout the calendar year. Random selection was performed to ensure as much as possible that longitudinal and cross-sectional households were comparable at baseline.
Study procedures were the same for households enrolled in the longitudinal cohort and cross-sectional surveys and began with community mobilization activities, including approvals from local chiefs and headmen. A field team was provided with images and coordinates of the randomly selected households. All individuals within a household were enumerated and were eligible to participate. Permission was obtained from the head of household and written informed consent was obtained from each individual present in the household. The consent process included a description of their participation in either the longitudinal cohort or cross-sectional survey. Not all participants in a household were required to participate.
During each study visit, a questionnaire was administered to each consenting participant older than 18 years of age residing within the household and to parents or guardians of those younger than 18 years of age. Data collected included demographic information, history of recent malaria and antimalarial treatment, knowledge of malaria transmission and prevention, and the use of ITNs. Participant's temperature was measured using a Braun Thermoscan® ear thermometer. A blood sample was collected by finger prick from consenting participants for a rapid diagnostic test (RDT) for malaria. The RDT (ICT Diagnostics, Cape Town, South Africa) detected P. falciparum histidine-rich protein 2 and was shown to detect 82% of test samples with wild-type P. falciparum at a concentration of 200 parasites/µL and 98% of test samples with a concentration of 2000 parasites/µL, with false positives in 0.6% of negative samples . Individuals who were RDT positive were offered treatment with artemether-lumefantrine (Coartem®) according to national guidelines.
Households selected for the longitudinal cohort were repeatedly surveyed approximately five times per calendar year (Figure 2). In the event that households withdrew or moved, replacement households were randomly selected from the sampling frame. In 2007 and 2008, the target sample size for the cohort was approximately 17 households. At the end of 2008, additional households were selected to increase the sample size to 24 in 2009.
Households selected for each cross-sectional survey were visited only once. Cross-sectional surveys were carried out approximately five times per calendar year. The target sample size for each cross sectional survey was the same as the target sample size per month of the corresponding cohort. For logistical reasons, the longitudinal and cross-sectional surveys were conducted in alternating months beginning April 2007 and February 2008.
The primary endpoint was the point prevalence of RDT positivity in the household. Analyses were conducted at two time points: 1) at baseline to determine whether the prevalence of RDT positivity differed between longitudinal and cross-sectional households at the first study visit prior to antimalarial treatment; and 2) during follow-up to determine whether the prevalence of RDT positivity differed between the longitudinal households throughout follow-up (with continued exposure to treatment of RDT positive individuals) and the cross-sectional households. For the baseline analysis, all study visits for participants in the cross-sectional households but only the first study visit for participants in the longitudinal households were included. For the follow-up analysis, all study visits for participants in the cross-sectional households were included but, for participants in the longitudinal households, the first study visit was excluded and only subsequent study visits were included.
For the primary analysis at both baseline and follow-up, logistic regression with a random intercept for households and robust standard error estimation was used to estimate the odds ratio of RDT positivity for the longitudinal compared to the cross-sectional households as randomized. Within-participant clustering was considered during follow-up, as participants in longitudinal households contributed multiple visits. However, the within-participant, intraclass correlation coefficient (ICC) was low (ICC = 0.00002); therefore, only within-household clustering is reported. Transmission season, high or low, was included in the models to account for temporal changes, and was defined based on rainfall data and pediatric hospitalizations for malaria at Macha Hospital during the study periods. Within a calendar year, the high transmission season was assumed to occur from January 1 to June 30 and from November 1 to December 31. For the 2008/2009 study period, season was defined across calendar years, such that high transmission seasons occurred from January 1 to June 30, 2008, November 1, 2008 to June 30, 2009, and November 1 to December 31, 2009. As RDT positivity was relatively common in 2007, the analysis was repeated using Poisson regression with robust standard error estimation (Table S1), which yielded similar inferences.
As a secondary analysis at both baseline and follow-up, multilevel logistic regression with a random intercept for households and robust standard error estimation was used to explore the contribution of individual and household level baseline characteristics. A two-level model was fit with individuals (level 1) nested within households (level 2). Both individual-level (e.g. age, sex, ITN use) and household-level (e.g. housing type, season) covariates that differed (p<0.10) between groups at baseline were considered for inclusion in the models.
Characteristics of the study population at the first study visit
In the 2007 study area, 174 participants from 34 households were enrolled in the cross-sectional group and 156 participants from 18 households were enrolled in the longitudinal group (Table 1 and 2; Figure 2). The characteristics of participants in each group were similar in terms of sex (% male: longitudinal[L]:42.3%; cross-sectional[C]:50.0%; p = 0.16), age (% <5 years: L:25.6%; C:21.1%; p = 0.30), and education (% adults with some secondary education: L:81.4%; C:70.4%; p = 0.35). The majority of participants did not own an ITN (L:61.5%; C:56.9%; p = 0.36). Participants differed significantly on their reporting of antimalarial use in the prior 2 weeks (L:12.2%; C:4.6%; p = 0.03), recent visit to a health center or post for an illness (L:50.0% less than one month ago; C:31.0%; p = 0.01) and for their last febrile episode (L:57.1%; C:30.5%; p<0.0001), and sleeping under an ITN at the time of the visit, among participants who owned an ITN (L:70.0%; C:25.3%; p<0.0001).
In the 2008/2009 study area, 917 participants from 166 households were enrolled in the cross-sectional group and 234 participants from 29 households were enrolled in the longitudinal group (Table 1 and 2; Figure 2). The characteristics of participants in each group were also similar in terms of sex (% male: L:47.4%; C:47.8%; p = 0.92), age (% <5 years: L:21.6%; C:19.4%; p = 0.52), and education (% adults with some secondary education: L:66.7%; C:65.1%; p = 0.62). Longitudinal and cross-sectional participants differed in their ownership (L:79.1% with ≥1 ITN; C:66.1%; p = 0.0003) and use of ITNs (L:63.2%; C:55.3%; p = 0.06), and their use of health services for their last febrile episode (L:53.9%; C:63.9%; p = 0.005).
Comparison of RDT positivity between cross-sectional and longitudinal groups at the first study visit prior to treatment exposure
In the 2007 study area, 41 participants (23.6%) from 21 households (61.8%) were RDT positive in the cross-sectional group, and 38 participants (24.4%) from 14 households (77.8%) were RDT positive in the longitudinal group (Figure 3A). Among cross-sectional households with at least one RDT positive individual, the median number of positive individuals was 2 (IQR:1, 3) for a median household prevalence of 30.0% (IQR:25.0, 50.0). Among longitudinal households with at least one RDT positive individual, the median number of positive individuals was 1.5 (IQR:1, 3) for a median household prevalence of 33.3% (IQR:12.5, 44.4). In both groups, the majority of infections were in children younger than 15 years. Only 10% of individuals who were RDT positive had a documented fever at the study visit, with the majority of symptomatic infections occurring among children 5–17 years of age.
In the primary analysis, no differences in the odds of RDT positivity were observed between households in the longitudinal cohort and cross-sectional surveys (odds ratio [OR]:0.97; 95% CI:0.46, 2.03) (Table 3). Some clustering of RDT positivity was observed within households (ICC:0.17; σ:0.81). Adjusting for season decreased the OR to 0.59 (95% CI:0.25, 1.39; ICC:0.17; σ:0.83), although this result was not statistically significant.
In the 2008/2009 study area, 36 participants (3.9%) from 23 households (13.9%) were RDT positive in the cross-sectional group, and 10 participants (4.3%) participants from 7 households (24.1%) were RDT positive in the longitudinal group (Figure 3B). Among cross-sectional households with at least one RDT positive individual, the median number of positive individuals was 1 (IQR:1, 1) for a median household prevalence of 20.0% (IQR:14.3, 33.3). Among longitudinal households with at least one RDT positive individual, the median number of positive individuals was 1 (IQR:1, 2) for a median household prevalence of 12.5% (IQR:11.1, 18.2). In both groups, the majority of infections were in children younger than 15 years. Only 15% of individuals who were RDT positive had a documented fever at the study visit, with the majority of symptomatic infections occurring among children 5–17 years of age.
In the primary analysis, no differences in the odds of RDT positivity were observed between households in the longitudinal cohort and cross-sectional surveys (OR:1.28; 95% CI:0.44, 3.79; ICC:0.40; σ:1.47) (Table 3). Similar to the findings in 2007, adjusting for season decreased the OR to 0.90 (95% CI:0.31, 2.65; ICC:0.35; σ:1.32), although this result was not statistically significant.
In both study areas, accounting for individual and household level characteristics at baseline did not significantly impact the results (Table 3).
Comparison of RDT positivity between cross-sectional and longitudinal groups during follow-up
In the 2007 study area, 174 participants from 34 households in the cross-sectional group and 126 participants from 17 households in the longitudinal group after their first visit were included in the analysis. Longitudinal participants contributed a median of 2 study visits (range:1, 3) and households were surveyed a median of 3 times (range:1, 4). In the longitudinal group, 38 infections were detected during follow-up from 33 individuals (three with 2 RDT positive results and one with 3 RDT positive results) in 10 households. The participants with multiple positive RDTs were all 5 years of age or younger. Individuals with positive RDTs within the same household were primarily found on the same study visit.
In the primary analysis, the odds of RDT positivity were significantly lower for households in the longitudinal group after the first visit compared to the cross-sectional households (OR:0.44; 95% CI:0.20, 0.96; ICC:0.18; σ:0.86) (Table 3; Figure 4A) and the results remained significant after adjusting for season (OR:0.37; 95% CI:0.16, 0.88; ICC:0.22; σ:0.98).
*includes all participants in the cross-sectional group and excludes the first study visit for participants in the longitudinal group.
In the 2008/2009 study area, 917 participants from 166 households in the cross-sectional group and 190 participants from 29 households in the longitudinal group after their first visit were included in the analysis. Longitudinal participants contributed a median of 3 study visits (range:1, 11) and households were surveyed a median of 10 times (range:1, 11). In the longitudinal group, six infections were detected during follow-up from six individuals in five households. The two infections in the same household were detected on different visits.
In the primary analysis, the odds of RDT positivity were significantly lower for households in the longitudinal group after the first visit compared to the cross-sectional households (OR:0.16; 95% CI:0.05, 0.55; ICC:0.39; σ:1.44) (Table 3; Figure 4B). The results remained significant after adjusting for season (OR:0.13; 95% CI:0.04, 0.41; ICC:0.30; σ:1.19). There was some evidence of a lowering of the household malaria risk over time as the odds ratio for RDT positivity was lower in subsequent follow-up visits in the longitudinal households compared to the cross-sectional households, suggesting a cumulative effect (first visit: crude OR = 0.44; 95% CI = 0.10, 1.93; second visit: OR = 0.15; 95% CI = 0.02, 1.45; third visit: OR = 0.16; 95% CI = 0.02, 1.61).
In both study areas, accounting for individual and household level characteristics at baseline did not significantly impact the results (Table 3).
We sought to quantify the effect of a proactive strategy of household screening and treatment with ACT of individuals infected with Plasmodium falciparum on the reduction in malaria transmission within households. The prevalence of parasitemia was significantly reduced in households repeatedly screened and treated compared to a control group of households. This effect was consistent across two geographic areas with different levels of malaria transmission. Strategies to reduce and interrupt malaria transmission through treatment of symptomatic and asymptomatic infections are possible with the use of ACT. Artemisinin derivatives are active against both young and mature asexual parasites and immature gametocytes , thus preventing gametocyte development and blocking transmission to mosquitoes. Studies have shown that gametocyte carriage is significantly reduced among individuals treated with artemisinin derivatives in comparison to other antimalarials , , , , . Artemisinin-based derivatives also have been shown to decrease both transmission to mosquitoes and the prevalence of high density oocyst infections within mosquitoes , .
In areas where malaria transmission has declined following implementation of effective control measures, additional strategies are needed to identify and treat asymptomatic or minimally symptomatic cases to eliminate reservoirs of infection, interrupt transmission and achieve elimination . Several case detection strategies have been developed and implemented. Passive case detection, involving identification of symptomatic patients seeking care at health facilities, requires the least resources. This strategy, however, does not detect asymptomatic or minimally symptomatic infections as these individuals will not present to health care facilities. The proportion of malaria cases that are asymptomatic or minimally symptomatic is substantial and can be as high as 96% , , , suggesting that the majority of infectious cases would be missed with passive case detection. Reactive case detection  extends this strategy based on the observation that malaria cases are spatially clustered and that cases identified at health centers (index cases) represent foci of infection within households and surrounding neighborhoods. With reactive case detection, residents of households of index cases and possibly of households in the immediate vicinity are screened and treated if found to be infected. However, little data exist on the appropriate radius from the index household that should be screened, and this radius likely varies in different epidemiological settings. In a study of reactive case detection in rural southern Zambia, the prevalence of malaria was found to be significantly higher among residents of households of index cases than among residents of randomly selected households in the area . However, even with reactive case detection, many infectious cases would be missed. In our community-based study, only 10–15% of RDT positive individuals were symptomatic with a documented fever and up to 70% of individuals reported they did not seek care for their last febrile episode. Consequently, most infected participants would have been missed through reactive case detection. In 2007, 79 individuals from 35 households were RDT positive at the first study visit; however, only 16 residents of 10 households reported fever and sought care. If these cases sought care and their households were screened, as in reactive case detection, 38 RDT positive individuals would have been detected, representing only 52% of all RDT positive individuals. In 2008/2009, the proportion of RDT positive individuals who would have gone undetected increased to 72%.
A second strategy to target asymptomatic or minimally symptomatic individuals is mass drug distribution, in which case detection is not attempted and drugs are distributed to a population regardless of symptoms and without diagnosis of infection. Mass drug distribution has a long history in malaria control, achieving transient reductions in incidence or prevalence but with little effect on transmission .
Lastly, a case detection strategy more intensive than passive or reactive case detection, but without treating the entire population, is proactive case detection , where populations are screened and infected individuals are treated (“test and treat”) as was done in this study. This strategy requires substantial resources for personnel and drugs, a rapid diagnostic test with a high positive predictive value, and a non-mobile population willing to accept screening and treatment of minimally symptomatic individuals. Proactive case detection may be an essential strategy to achieve elimination in regions of sub-Saharan Africa where the burden of malaria has been substantially reduced with current control efforts. Proactive case detection has successfully been implemented in Morocco , Brazil , Taiwan , and Southern China , where levels of malaria transmission are lower than in much of sub-Saharan Africa. However, these studies evaluated the success of proactive case detection based on the burden of malaria before and after implementation of a case detection program, without concurrent control groups.
To our knowledge, this is the first formal quantification of the effect size of proactive case detection with ACT using a concurrent comparison group. Although the findings were consistent in two adjacent areas with different levels of malaria transmission, the reduction in malaria prevalence appeared to be greater in the study area with a lower level of transmission intensity. Proactive case detection resulted in a six-fold reduction in prevalence in 2008/2009, where the initial parasite prevalence was 4%, but in only a two-fold reduction in 2007, where the initial prevalence was 24%, suggesting that proactive case detection may have greater impact on malaria transmission in areas where current control measures have succeeded in reducing transmission. These results are consistent with the predicted impact of artemisinin-based therapies in different transmission settings .
This study had several limitations. First, as a trial could not be conducted for ethical reasons, this observational study was designed as a cohort study with a series of cross-sectional studies for comparison. Households enrolled in the longitudinal cohort study were repeatedly surveyed and it is possible that the behaviors of household residents were influenced by participation in the study. Indeed, ITN use during follow-up was higher for individuals in the cohort compared to the cross-sectional surveys, particularly during the low transmission season (data not shown). Consequently, it is possible that the effect of proactive case detection was overestimated in longitudinal households. In addition, despite the random selection of households, differences between the cross-sectional and longitudinal households and their residents were identified at baseline that may have impacted their risk of malaria, including ownership and use of ITNs. These differences in ITN use were primarily attributable to the seasons in which the longitudinal (high transmission) and cross-sectional (high and low transmission) households were enrolled and were not apparent after adjustment (data not shown). However, the decreased odds of RDT positivity in the longitudinal households at baseline after adjusting for season may indicate that the effect of proactive case detection during follow-up was overestimated. Second, for ethical reasons all RDT positive individuals in both the cross-sectional and longitudinal groups were treated with ACT. Given the potential for ACT to reduce malaria transmission, there may have been an indirect protective effect conferred to residents living in proximity to households where participants were treated. Consequently, the impact of this strategy may have been underestimated. Lastly, the sensitivity of the RDT decreases at lower parasite densities , and infections in individuals with low levels of parasitemia could have been missed. We do not expect this misclassification to have occurred differentially between participants in longitudinal and cross-sectional households, and therefore the effect of this strategy may have been underestimated.
In summary, proactive case detection with treatment using ACT can reduce transmission and provide indirect protection to household members. If resources permit, this strategy could be targeted to focal areas of transmission within regions in the pre-elimination phase of malaria control to achieve further reductions in malaria transmission.
Conceived and designed the experiments: WJM HH TS SM PET GG. Performed the experiments: TK HH TS SM PET GG. Analyzed the data: CGS TAL. Wrote the paper: CGS WJM.
- 1. WHO (2010) World malaria report 2010. Geneva, Switzerland: World Health Organization. WHO2010World malaria report 2010Geneva, SwitzerlandWorld Health Organization
- 2. Aregawi MW, Ali AS, Al-Mafazy AW, Molteni F, Katikiti S, et al. (2011) Reductions in malaria and anaemia case and death burden at hospitals following scale-up of malaria control in Zanzibar, 1999–2008. Malar J 10: 46.MW AregawiAS AliAW Al-MafazyF. MolteniS. Katikiti2011Reductions in malaria and anaemia case and death burden at hospitals following scale-up of malaria control in Zanzibar, 1999–2008.Malar J1046
- 3. Otten M, Aregawi M, Were W, Karema C, Medin A, et al. (2009) Initial evidence of reduction of malaria cases and deaths in Rwanda and Ethiopia due to rapid scale-up of malaria prevention and treatment. Malar J 8: 14.M. OttenM. AregawiW. WereC. KaremaA. Medin2009Initial evidence of reduction of malaria cases and deaths in Rwanda and Ethiopia due to rapid scale-up of malaria prevention and treatment.Malar J814
- 4. Barnes KI, Chanda P, Ab Barnabas G (2009) Impact of the large-scale deployment of artemether/lumefantrine on the malaria disease burden in Africa: case studies of South Africa, Zambia and Ethiopia. Malar J 8: Suppl 1S8.KI BarnesP. ChandaG. Ab Barnabas2009Impact of the large-scale deployment of artemether/lumefantrine on the malaria disease burden in Africa: case studies of South Africa, Zambia and Ethiopia.Malar J8Suppl 1S8
- 5. Moonen B, Cohen JM, Snow RW, Slutsker L, Drakeley C, et al. (2010) Operational strategies to achieve and maintain malaria elimination. Lancet 376: 1592–1603.B. MoonenJM CohenRW SnowL. SlutskerC. Drakeley2010Operational strategies to achieve and maintain malaria elimination.Lancet37615921603
- 6. Mabunda S, Aponte JJ, Tiago A, Alonso P (2009) A country-wide malaria survey in Mozambique. II. Malaria attributable proportion of fever and establishment of malaria case definition in children across different epidemiological settings. Malar J 8: 74.S. MabundaJJ AponteA. TiagoP. Alonso2009A country-wide malaria survey in Mozambique. II. Malaria attributable proportion of fever and establishment of malaria case definition in children across different epidemiological settings.Malar J874
- 7. Vafa M, Troye-Blomberg M, Anchang J, Garcia A, Migot-Nabias F (2008) Multiplicity of Plasmodium falciparum infection in asymptomatic children in Senegal: relation to transmission, age and erythrocyte variants. Malar J 7: 17.M. VafaM. Troye-BlombergJ. AnchangA. GarciaF. Migot-Nabias2008Multiplicity of Plasmodium falciparum infection in asymptomatic children in Senegal: relation to transmission, age and erythrocyte variants.Malar J717
- 8. Dal-Bianco MP, Koster KB, Kombila UD, Kun JF, Grobusch MP, et al. (2007) High prevalence of asymptomatic Plasmodium falciparum infection in Gabonese adults. Am J Trop Med Hyg 77: 939–942.MP Dal-BiancoKB KosterUD KombilaJF KunMP Grobusch2007High prevalence of asymptomatic Plasmodium falciparum infection in Gabonese adults.Am J Trop Med Hyg77939942
- 9. Baliraine FN, Afrane YA, Amenya DA, Bonizzoni M, Menge DM, et al. (2009) High prevalence of asymptomatic plasmodium falciparum infections in a highland area of western Kenya: a cohort study. J Infect Dis 200: 66–74.FN BaliraineYA AfraneDA AmenyaM. BonizzoniDM Menge2009High prevalence of asymptomatic plasmodium falciparum infections in a highland area of western Kenya: a cohort study.J Infect Dis2006674
- 10. Ogutu B, Tiono AB, Makanga M, Premji Z, Gbadoe AD, et al. (2010) Treatment of asymptomatic carriers with artemether-lumefantrine: an opportunity to reduce the burden of malaria? Malar J 9: 30.B. OgutuAB TionoM. MakangaZ. PremjiAD Gbadoe2010Treatment of asymptomatic carriers with artemether-lumefantrine: an opportunity to reduce the burden of malaria?Malar J930
- 11. Price RN, Nosten F, Luxemburger C, ter Kuile FO, Paiphun L, et al. (1996) Effects of artemisinin derivatives on malaria transmissibility. Lancet 347: 1654–1658.RN PriceF. NostenC. LuxemburgerFO ter KuileL. Paiphun1996Effects of artemisinin derivatives on malaria transmissibility.Lancet34716541658
- 12. Sutherland CJ, Ord R, Dunyo S, Jawara M, Drakeley CJ, et al. (2005) Reduction of malaria transmission to Anopheles mosquitoes with a six-dose regimen of co-artemether. PLoS Med 2: e92.CJ SutherlandR. OrdS. DunyoM. JawaraCJ Drakeley2005Reduction of malaria transmission to Anopheles mosquitoes with a six-dose regimen of co-artemether.PLoS Med2e92
- 13. Okell LC, Drakeley CJ, Ghani AC, Bousema T, Sutherland CJ (2008) Reduction of transmission from malaria patients by artemisinin combination therapies: a pooled analysis of six randomized trials. Malar J 7: 125.LC OkellCJ DrakeleyAC GhaniT. BousemaCJ Sutherland2008Reduction of transmission from malaria patients by artemisinin combination therapies: a pooled analysis of six randomized trials.Malar J7125
- 14. Moss WJ, Hamapumbu H, Kobayashi T, Shields T, Kamanga A, et al. (2011) Use of remote sensing to identify spatial risk factors for malaria in a region of declining transmission: a cross-sectional and longitudinal community survey. Malar J 10: 163.WJ MossH. HamapumbuT. KobayashiT. ShieldsA. Kamanga2011Use of remote sensing to identify spatial risk factors for malaria in a region of declining transmission: a cross-sectional and longitudinal community survey.Malar J10163
- 15. Sutcliffe CG, Kobayashi T, Hamapumbu H, Shields T, Kamanga A, et al. (2011) Changing individual-level risk factors for malaria with declining transmission in southern Zambia: a cross-sectional study. Malar J 10: 324.CG SutcliffeT. KobayashiH. HamapumbuT. ShieldsA. Kamanga2011Changing individual-level risk factors for malaria with declining transmission in southern Zambia: a cross-sectional study.Malar J10324
- 16. Kent RJ, Thuma PE, Mharakurwa S, Norris DE (2007) Seasonality, blood feeding behavior, and transmission of Plasmodium falciparum by Anopheles arabiensis after an extended drought in southern Zambia. Am J Trop Med Hyg 76: 267–274.RJ KentPE ThumaS. MharakurwaDE Norris2007Seasonality, blood feeding behavior, and transmission of Plasmodium falciparum by Anopheles arabiensis after an extended drought in southern Zambia.Am J Trop Med Hyg76267274
- 17. Larkin GL, Thuma PE (1991) Congenital malaria in a hyperendemic area. Am J Trop Med Hyg 45: 587–592.GL LarkinPE Thuma1991Congenital malaria in a hyperendemic area.Am J Trop Med Hyg45587592
- 18. Lowther SA, Curriero FC, Shields T, Ahmed S, Monze M, et al. (2009) Feasibility of satellite image-based sampling for a health survey among urban townships of Lusaka, Zambia. Trop Med Int Health 14: 70–78.SA LowtherFC CurrieroT. ShieldsS. AhmedM. Monze2009Feasibility of satellite image-based sampling for a health survey among urban townships of Lusaka, Zambia.Trop Med Int Health147078
- 19. WHO (2009) Malaria rapid diagnostic test performance: results of WHO product testing of malaria RDTs: round 1 (2008). France: World Health Organization. WHO2009Malaria rapid diagnostic test performance: results of WHO product testing of malaria RDTs: round 1 (2008)FranceWorld Health Organization
- 20. von Seidlein L, Milligan P, Pinder M, Bojang K, Anyalebechi C, et al. (2000) Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial. Lancet 355: 352–357.L. von SeidleinP. MilliganM. PinderK. BojangC. Anyalebechi2000Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial.Lancet355352357
- 21. Adjuik M, Babiker A, Garner P, Olliaro P, Taylor W, et al. (2004) Artesunate combinations for treatment of malaria: meta-analysis. Lancet 363: 9–17.M. AdjuikA. BabikerP. GarnerP. OlliaroW. Taylor2004Artesunate combinations for treatment of malaria: meta-analysis.Lancet363917
- 22. von Seidlein L, Bojang K, Jones P, Jaffar S, Pinder M, et al. (1998) A randomized controlled trial of artemether/benflumetol, a new antimalarial and pyrimethamine/sulfadoxine in the treatment of uncomplicated falciparum malaria in African children. Am J Trop Med Hyg 58: 638–644.L. von SeidleinK. BojangP. JonesS. JaffarM. Pinder1998A randomized controlled trial of artemether/benflumetol, a new antimalarial and pyrimethamine/sulfadoxine in the treatment of uncomplicated falciparum malaria in African children.Am J Trop Med Hyg58638644
- 23. Owusu-Agyei S, Smith T, Beck HP, Amenga-Etego L, Felger I (2002) Molecular epidemiology of Plasmodium falciparum infections among asymptomatic inhabitants of a holoendemic malarious area in northern Ghana. Trop Med Int Health 7: 421–428.S. Owusu-AgyeiT. SmithHP BeckL. Amenga-EtegoI. Felger2002Molecular epidemiology of Plasmodium falciparum infections among asymptomatic inhabitants of a holoendemic malarious area in northern Ghana.Trop Med Int Health7421428
- 24. Harris I, Sharrock WW, Bain LM, Gray KA, Bobogare A, et al. (2010) A large proportion of asymptomatic Plasmodium infections with low and sub-microscopic parasite densities in the low transmission setting of Temotu Province, Solomon Islands: challenges for malaria diagnostics in an elimination setting. Malar J 9: 254.I. HarrisWW SharrockLM BainKA GrayA. Bobogare2010A large proportion of asymptomatic Plasmodium infections with low and sub-microscopic parasite densities in the low transmission setting of Temotu Province, Solomon Islands: challenges for malaria diagnostics in an elimination setting.Malar J9254
- 25. Stresman GH, Kamanga A, Moono P, Hamapumbu H, Mharakurwa S, et al. (2010) A method of active case detection to target reservoirs of asymptomatic malaria and gametocyte carriers in a rural area in Southern Province, Zambia. Malar J 9: 265.GH StresmanA. KamangaP. MoonoH. HamapumbuS. Mharakurwa2010A method of active case detection to target reservoirs of asymptomatic malaria and gametocyte carriers in a rural area in Southern Province, Zambia.Malar J9265
- 26. von Seidlein L, Greenwood BM (2003) Mass administrations of antimalarial drugs. Trends Parasitol 19: 452–460.L. von SeidleinBM Greenwood2003Mass administrations of antimalarial drugs.Trends Parasitol19452460
- 27. El KhyariT (1999) KhyariT El1999Malaria elimination strategy in Morocco: plan and elements of evaluation. Malaria elimination strategy in Morocco: plan and elements of evaluation.
- 28. Macauley C (2005) Aggressive active case detection: a malaria control strategy based on the Brazilian model. Soc Sci Med 60: 563–573.C. Macauley2005Aggressive active case detection: a malaria control strategy based on the Brazilian model.Soc Sci Med60563573
- 29. Yip K (2000) Malaria eradication: the Taiwan experience. Parassitologia 42: 117–126.K. Yip2000Malaria eradication: the Taiwan experience.Parassitologia42117126
- 30. Zizhao L, Luoyuan S, Lian Z, Dongfang L, Yunpu S (1999) Control strategies of malaria in Henan Province, China. Southeast Asian J Trop Med Public Health 30: 240–242.L. ZizhaoS. LuoyuanZ. LianL. DongfangS. Yunpu1999Control strategies of malaria in Henan Province, China.Southeast Asian J Trop Med Public Health30240242
- 31. Okell LC, Drakeley CJ, Bousema T, Whitty CJ, Ghani AC (2008) Modelling the impact of artemisinin combination therapy and long-acting treatments on malaria transmission intensity. PLoS Med 5: e226; discussion e226.LC OkellCJ DrakeleyT. BousemaCJ WhittyAC Ghani2008Modelling the impact of artemisinin combination therapy and long-acting treatments on malaria transmission intensity.PLoS Med5e226; discussion e226